Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Feb;52(1):96-103.
doi: 10.1007/s10578-020-00993-8.

The Visuo-Motor Attention Test in Boys with Attention Deficit Hyperactivity Disorder (ADHD): Methylphenidate-Placebo Randomized Controlled Trial

Yaffa Hadar  1 , Shraga Hocherman  2 , Oren Lamm  3 , Emanuel Tirosh  2   4
Affiliations
Randomized Controlled Trial

The Visuo-Motor Attention Test in Boys with Attention Deficit Hyperactivity Disorder (ADHD): Methylphenidate-Placebo Randomized Controlled Trial

Yaffa Hadar et al. Child Psychiatry Hum Dev. 2021 Feb.

Abstract

To assess the visuomotor attention ability in children with ADHD and controls and their response to placebo and Methylphenidate (MPH) treatment. 36 boys with ADHD and 36 age matched typical controls were administered the visuomotor attention test (VMAT) as a baseline and following a week of MPH(IR) or placebo administered to the study group, in a randomized crossover design. A significant difference between the study and control groups was found on several VMAT measures. No performance difference between ADHD dimensional sub-types was observed at the baseline assessment. Under MPH treatment a significant improvement in VMAT measures was observed and particularly in the combined and predominantly hyperactive (C\HI) type. The VMAT results obtained in the present study are consistent with previous findings. ADHD subtypes appear similarly short of visuomotor attention resources; a visuomotor test can be used in the assessment of gains derived from MPH treatment.

Keywords: ADHD; ADHD subtype; Methylphenidate; Placebo.

PubMed Disclaimer

References

    1. Goulardins JB, Rigoli D, Licari M, Piek JP, Hasue RH, Oosterlaan J et al (2015) Attention deficit hyperactivity disorder and developmental coordination disorder: two separate disorders or do they share a common etiology. J Behav Brain Res 292:484–492
    1. Schoemaker MM, Ketelaars CEJ, van Zonneveld M, Minderaa RB, Mulder T (2005) Deficits in motor control processes involved in production of graphic movements of children with attention-deficit-hyperactivity disorder. J Dev Med Child Neurol 47(6):390–395
    1. Langmaid RA, Papadopoulous N, Johnson BP, Phillips J, Rinehart NJ (2016) Movement scaling in children with ADHD-combined type. J Atten Disord 20:131–137 - PubMed
    1. Pitcher TM, Piek JP, Barrett NC (2002) Timing and force control in boys with attention deficit hyperactivity disorder: Subtype differences and the effect of comorbid developmental coordination disorder. Hum Mov Sci 21:919–945 - PubMed
    1. Kaiser ML, Schoemaker MM, Albaret JM, Geuze RH (2015) What is the evidence of impaired motor skills and motor control among children with attention deficit hyperactivity disorder (ADHD)? Systematic review of the literature. Res Dev Disabil 36:338–357

Publication types

MeSH terms

Substances

LinkOut - more resources